Crow IPO Review

May Apply

First-mover advantage may click here.

Avoid

Nothing extraordinary in this company to ask for such a high valuation. With a market that's a bit jittery leading up to the budget, it's better to stay away.

May Apply

Greedy valuation for a good company but looking at the GMP it would be foolish to skip this.

1

Apply

Good GMP, decent business, ride the IPO euphoria.

May Apply

Apply if GMP appears and QIB subscription goes beyond 30x.

Apply

Best IPO this week.

May Apply

Average SoBo realtor focusing on luxury apartments. Decent bet if QIB is enthusiastic.

May Apply

Micro finance lender focusing on unsecured loans to individuals in business-agnostic market like Kerala. Ride the wav if GMP sustains and QIB shows interest.

May Apply

Looking at the wild interest in this counter before listing and tiny issue, the best strategy would be to apply and sell on listing if allotted.

Apply

A leader in a niche business with global hands. Must apply.

Apply

Decent company in an unattractive sector. Go for listing gains only.

Apply

Nothing fancy here but the high GMP and overall IPO euphoria makes this a ship worth not missing.

Neutral

Nothing fancy and I usually do not go long on auxiliary automobile companies.

May Apply

A decent company that only deals with the government. Nothing extraordinary.

May Apply

Not a fan of the sector but this one is coming at the right time with the right price. Exit on listing.

Neutral

Difficult to assess this IPO as it has a mix of euphoria and poor economics.

Neutral

Good brand but high valuation in a terrible market.

Apply

Niche healthcare player that supports the diagnostics and FMCG industry. A good bet.

Apply

IRM Energy is a growing company with a focus on natural gas and other non-polluting fuels. This is a good bet.

Neutral

Small issue, small business, very low chance of allotment. No recommendation.

Neutral

Difficult to review this because it's a single-product API company asking for money to start a subsidiary.

Avoid

Integrated facilities management as a business doesn't impress me.

Apply

I don't see any red flag save for the market concentration and invisible GMP.

Apply

Valuations are a bit on the higher side but good bet.

Neutral

Continuously loss-making. Avoid unless QIB subscription surprises.

Neutral

Apply only if QIB crosses 5x.

Avoid

I don't see any reason for anyone to apply. Thanks.

Avoid

A player in a niche business with stupid margins.

Neutral

Good company with a bad track record. Only aggressive risk-takers may apply if QIB crosses 3x.

Apply

RR Kabel's brand is good enough for a small listing gain. Risk-takers should apply.

Apply

Listing gain candidate only.

Apply

Hospital stocks never disappoint. This is also good for listing gains.

Apply

Ignoring Capital Market's 39 rating this time will help. Thanks.

Apply

With no listed peers and parent company (SAT Industries) trading near ATH, the market participation prospects of Aeroflex Industries looks good. It's poised well for its debut, thanks to its small issue, decent financials, and a good GMP command so far. My only concern is regarding the asking price. With a P/E of 46.3, Aeroflex is surely wearing the greed cap and hoping to take the first mover advantage in its niche. I'll apply with FF however.

Neutral

At first look, Pyramid Technoplast IPO looks decent. Only the low GMP and T-group listing are matters of concern at this point. Will apply with FF if QIB crosses 30x and exit at listing. Tough allotment mostly. Thanks.

Neutral

When there are established players such as Blue Dart and TCI Express in the market with attractive valuations, it's meaningless to invest in TVS SCS for the long run at the moment. Especially when the GMP is non-existent, valuations are 4x its peers, and the sector itself marred with several challenges such as fuel prices. The only respite from my POV is the 10% retail quota.

It's an avoid candidate for me at the moment but I may consider getting 1 retail lot if QIB crosses 30x on day 3.

1

Neutral

Concord Biotech has too many red flags for me to give it a "Subscribe" rating. Falling GMP aside, it's a full OFS issue with a P/E and P/B higher than the mean of its legendary peers like Lupin, Divi's, and Aurobindo. There's nothing left on the table also because there's no fancy here.

It is possible that the GMP vanishes by listing date, especially in a tricky market that's corrected by about 1% since its July 2023 ATHs.

I will apply for 1 retail lot only if QIB crosses 3x on day 3. Thanks.

Apply

I have a general aversion to MSME lenders and NBFCs because they are more prone to bad loans for which RBI still hasn't found a foolproof panacea. I usually stay away from them, most recently being Five Star Business and Fusion Micro.

That being said, SBFC Finance has a healthy book and management. It's worth taking some risk here, especially in comparison with Concord Biotech. The high P/E is concerning, so I will apply with FF in retail only if QIB crosses 30x on day 3. Thanks.

1

Neutral

Hospitals give good profits to shareholders as they are often profit-making businesses. Except for the falling GMP, I don't see any major red flags in Yatharth Hospital IPO. Apply with FF if QIB crosses 30x on day 3. Thanks.

Apply

Netweb Technologies reminds me of both first-movers in their industry and tech-favourites. The euphoria around its IPO is palpable and with the markets at ATH, it's bound to open like a blockbuster.

Save for the high OFS portion, poor face value, and aggressive valuations - all of which signal the systemic greed in promoters - I don't see many red flags in this issue. But thanks to the GMP and potential high subscription figures, I'll be dabbling in this IPO for pure listing gains. Thanks.

2

Apply

Another rare IPO with no red flags (Cyient DLM had only one), this seems like a decent thing to bet on. I'm not a fan of SFBs and rarely venture into them, but Utkarsh SFB seems like a game-changer. At a very good valuation, this one has kept something on the table for investors.

Applied with FF as allotment looks very difficult. Thanks.

Apply

Senco Gold is coming at a good valuation and that's perhaps the only good and relevant point for this IPO. As many other members have mentioned here, gold or jewellery-based companies rarely reward shareholders (with the slightly irrelevant exception of Titan).

However, this is a carefully orchestrated IPO and there WILL be some listing gain. If not a 30% pop, it may rise by at least 10%. I see no major red flags here. I will apply to gain 1 retail lot. QIB may cross 30x. Thanks.

Neutral

No fancy in this company as it has no specialization or any other redeeming quality. Look for subscription and apply.

Apply

A rare IPO with no red flags. Apply with full force for listing gains.

Apply

Other than the high asking price (P/E for 87) and being over-dependent on the defense sector, I don't see any negative in ideaForge. With a GMP that's inching closer to 100% and the mindblowing Dec 2022 listing of DroneAcharya, there is no reason not to ride this IPO euphoria. Retail allotment will be very tough so apply only on the 4th day to avoid locking your funds from now. Thanks.

Neutral

A business with no peers to compare with is a tricky one. It's one of the largest buffalo meat exporters, which is a profitable business and I see PAT growing YoY. A section of investors will stay away from this due to religious concerns, so it's possible that institutions will lap it up. While GMP isn't high, I believe the subscriptions will be a good indicator whether to apply or not.

Neutral

Whenever a company offers its initial shares with more than 35% retail quota, I get sceptical. In recent memory, USK Infra (LC on day close), Abans Holdings (LC on day close), Uma Exports (languishing below IPO price), and Exxaro Tiles (now below IPO price) have all given negative returns in the short-term.

However, it's worth noting that IKIO Lighting has GMP's godly hands as a support which was not the case in any of these IPOs. Stay neutral on this and look for subscription figures.

Neutral

I don't see much fancy in this sector nor in the company. With a large OFS portion and below average financials, I'm not ready to take any risk in this volatile market. Will only apply to get 1 retail lot if QIB crosses 3x and total subs is 2x. Thanks.

Neutral

The 60% retail quota and T-Group listing aside, I believe the company is a good bet with decent valuations and asking price. Yet, it may surprise on listing and I'm not sure about that in this volatile market. Apply with caution if QIB crosses 30X. Thanks.

Neutral

Nothing fancy here and I'm not a fan of natural materials and its related businesses. With 35% retail quota and a very volatile market, I suggest being cautious. Aggressive risk-takers in retail can apply only if QIB crosses 30x.